Monoclonal antibodies against ββ-amyloid (Aββ) for the treatment of Alzheimer's disease: the Aββ target at a crossroads

Author: Panza Francesco   Frisardi Vincenza   Imbimbo Bruno P   Seripa Davide   Solfrizzi Vincenzo   Pilotto Alberto  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.11, Iss.6, 2011-06, pp. : 679-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content